Filtros de búsqueda

Lista de obras de Parnetti L

19th biennial IPEG Meeting

1st Conference Clinical Trials on Alzheimer’s Disease September 17-18-19, 2008 School of Medecine Montpellier, France

article

A Practical Guide to Immunoassay Method Validation

artículo científico publicado en 2015

A combination of CSF tau ratio and midsaggital midbrain-to-pons atrophy for the early diagnosis of progressive supranuclear palsy

artículo científico publicado en 2010

A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance.

artículo científico publicado en 2006

A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation.

artículo científico publicado en 2018

A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies

artículo científico publicado en 2020

Abnormal cortical neural synchronization mechanisms in quiet wakefulness are related to motor deficits, cognitive symptoms, and visual hallucinations in Parkinson's disease patients: an electroencephalographic study

scientific article published on 12 March 2020

Abnormalities of functional cortical source connectivity of resting-state electroencephalographic alpha rhythms are similar in patients with mild cognitive impairment due to Alzheimer's and Lewy body diseases

artículo científico publicado en 2019

Abnormalities of resting-state EEG in patients with prodromal and overt dementia with Lewy bodies: Relation to clinical symptoms

artículo científico publicado en 2020

Accuracy and reproducibility of automated white matter hyperintensities segmentation with lesion segmentation tool: A European multi-site 3T study

artículo científico publicado en 2020

Age and diagnostic performance of Alzheimer disease CSF biomarkers.

artículo científico publicado en 2012

Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study

scientific article published on 20 August 2020

Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology

artículo científico publicado en 2018

Amygdalar nuclei and hippocampal subfields on MRI: test-retest reliability of automated volumetry across different MRI sites and vendors

scientific article published on 13 May 2020

Analytical performance and clinical utility of the INNOTEST PHOSPHO-TAU181P assay for discrimination between Alzheimer's disease and dementia with Lewy bodies

artículo científico publicado en 2006

Are We Ready for Detecting α-Synuclein Prone to Aggregation in Patients? The Case of "Protein-Misfolding Cyclic Amplification" and "Real-Time Quaking-Induced Conversion" as Diagnostic Tools.

artículo científico publicado en 2018

Arterial hypertension and cognitive dysfunction in physiologic and pathologic aging of the brain

artículo científico publicado en 2007

Arterial hypertension and stroke prevention: an update

artículo científico publicado en 2006

Association Between Migraine and Headache Attributed to Stroke: A Case-Control Study

artículo científico publicado en 2008

Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI).

artículo científico publicado en 2017

Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia

artículo científico publicado en 2017

Associations of Alzheimer's disease with macular degeneration.

artículo científico publicado en 2017

Atherosclerosis assessment confounders in the Rancho Bernardo study.

artículo científico publicado en 2007

Biochemical diagnosis of neurodegenerative diseases gets closer ⬇️

artículo científico publicado el 1 de marzo de 2011

Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders

artículo científico

Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease

artículo científico publicado en 2019

Biomarker-Based Signature of Alzheimer's Disease in Pre-MCI Individuals

scientific article published on 23 August 2019

Biomarkers for Early Diagnosis of Alzheimer's Disease in the Oldest Old: Yes or No?

artículo científico publicado en 2017

Biomarkers in Parkinson's disease: From pathophysiology to early diagnosis

scientific article published on 01 June 2016

Brain CT scan in acute ischemic stroke: early signs and functional outcome.

artículo científico publicado en 2002

Brain CT-scan in acute stroke patients: silent infarcts and relation to outcome.

artículo científico publicado en 2002

CSF Biomarkers Profile in CADASIL-A Model of Pure Vascular Dementia: Usefulness in Differential Diagnosis in the Dementia Disorder.

artículo científico publicado en 2010

CSF Biomarkers for Early Diagnosis of Synucleinopathies: Focus on Idiopathic RBD

scientific article published on 14 January 2019

CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment

scientific article published on 27 October 2020

CSF and blood biomarkers for Parkinson's disease

scientific article published on 10 April 2019

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

artículo científico publicado en 2009

CSF cutoffs for MCI due to AD depend on APOEε4 carrier status

artículo científico publicado en 2019

CSF levels of heart fatty acid binding protein are altered during early phases of Alzheimer's disease

artículo científico publicado en 2010

Case of posterior cortical atrophy (PCA) evolved to PCA-CBS

artículo científico publicado en 2018

Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer's Disease

artículo científico publicado en 2016

Cerebrospinal Fluid Biomarkers for Target Engagement and Efficacy in Clinical Trials for Alzheimer's and Parkinson's Diseases

artículo científico publicado en 2016

Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: An Invaluable Tool for Clinical Diagnosis and Trial Enrichment

artículo científico publicado en 2018

Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias

scientific article published on 05 April 2011

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

artículo científico publicado en 2017

Cerebrospinal fluid and serum d-serine concentrations are unaltered across the whole clinical spectrum of Alzheimer's disease

artículo científico publicado en 2020

Cerebrospinal fluid biochemical markers in early detection and in differential diagnosis of dementia disorders in routine clinical practice ⬇️

artículo científico publicado el 1 de octubre de 2003

Cerebrospinal fluid biomarkers and prediction of conversion in patients with mild cognitive impairment: 4-year follow-up in a routine clinical setting.

artículo científico publicado en 2009

Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis.

artículo científico publicado en 2017

Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice

artículo científico publicado en 2016

Cerebrospinal fluid biomarkers in Parkinson disease

artículo científico

Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.

artículo científico publicado en 2008

Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases

artículo científico publicado en 2014

Cerebrospinal fluid in Alzheimer's: A precious tool.

artículo científico publicado en 2016

Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors.

artículo científico publicado en 2002

Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease

artículo científico publicado en 2014

Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis

artículo científico publicado en 2019

Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis

artículo científico publicado en 2019

Cerebrospinal fluid neuron-specific enolase: a further marker of Alzheimer's disease?

artículo científico publicado en 2008

Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients.

artículo científico publicado en 2017

Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease.

artículo científico publicado en 2010

Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease

artículo científico publicado en 2013

Changes of olfactory tract in Parkinson's disease: a DTI tractography study

artículo científico publicado en 2020

Characteristics of delayed admission to stroke unit

artículo científico publicado en 2006

Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson's Disease and Dementia with Lewy Bodies

artículo científico publicado en 2018

Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation?

artículo científico publicado en 2007

Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study'.

artículo científico publicado en 2016

Clinical and genetic analysis of an Italian family with Machado-Joseph disease

article

Clinical and genetic analysis of hereditary and sporadic ataxia in central Italy.

artículo científico publicado en 2001

Coenzyme Q10, hyperhomocysteinemia and MTHFR C677T polymorphism in levodopa-treated Parkinson's disease patients

artículo científico publicado en 2012

Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers

artículo científico publicado en 2021

Cognitive performances in patients affected by late-onset epilepsy with unknown etiology: A 12-month follow-up study

artículo científico publicado en 2019

Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

artículo científico publicado en 2021

Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics

artículo científico publicado en 2016

Consensus guidelines for lumbar puncture in patients with neurological diseases

artículo científico publicado en 2017

Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia

scholarly article by Barbara Borroni et al published 29 October 2014 in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Diagnosing prodromal Alzheimer's disease: role of CSF biochemical markers

artículo científico publicado en 2005

Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosis

artículo científico publicado en 2019

Diagnostic utility of CSF α-synuclein species in Parkinson's disease: protocol for a systematic review and meta-analysis

artículo científico publicado en 2016

Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis.

artículo científico publicado en 2017

Differences in extracellular matrix production and basic fibroblast growth factor response in skin fibroblasts from sporadic and familial Alzheimer's disease

artículo científico publicado en 2007

Differential diagnosis between Alzheimer's disease and other dementias: Role of cerebrospinal fluid biomarkers

artículo científico publicado en 2019

Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease

artículo científico

Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia

artículo científico publicado en 2017

Differential sialylation of serpin A1 in the early diagnosis of Parkinson's disease dementia

artículo científico publicado en 2012

Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson's disease.

artículo científico publicado en 2017

Dissecting the Interactions between Human Serum Albumin and α-Synuclein: New Insights on the Factors Influencing α-Synuclein Aggregation in Biological Fluids

artículo científico publicado en 2019

Drug-induced Creutzfeldt-Jakob disease-like syndrome: early CSF analysis as useful tool for differential diagnosis

artículo científico publicado en 2018

Dual antiplatelet therapy in secondary prevention of ischemic stroke: a ghost from the past or a new frontier?

artículo científico publicado en 2010

Dysphagia following Stroke.

artículo científico publicado en 2004

Effect of Acetyl- L -Carnitine on Serum Levels of Cortisol and Adrenocorticotropic Hormone and Its Clinical Effect in Patients with Senile Dementia of Alzheimer Type

scholarly article by Lucilla Parnetti et al published 1990 in Dementia and Geriatric Cognitive Disorders

Effect of treatment with choline alphoscerate on hippocampus microanatomy and glial reaction in spontaneously hypertensive rats

artículo científico publicado en 2006

Efficacy of thrombolytic (rt-PA) therapy in old stroke patients: the Perugia Stroke Unit experience

artículo científico publicado en 2006

Emerging topics and practical aspects for an appropriate use of amyloid PET in the current Italian context

scientific article published on 24 April 2018

Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease

scientific article published on 14 September 2019

Entacapone reduces cortical activation in Parkinson's disease with wearing-off: a f-MRI study.

artículo científico publicado en 2014

Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link?

artículo científico publicado en 2016

Estimating the inheritance of frontotemporal lobar degeneration in the Italian population

artículo científico publicado en 2014

Evidence for Elevated Cerebrospinal Fluid ERK1/2 Levels in Alzheimer Dementia

artículo científico publicado en 2011

Evidence of practice effect in CANTAB spatial working memory test in a cohort of patients with mild cognitive impairment.

artículo científico publicado en 2017

Factors influencing the measurement of lysosomal enzymes activity in human cerebrospinal fluid

artículo científico publicado en 2014

Fingerprinting Alzheimer's Disease by 1H Nuclear Magnetic Resonance Spectroscopy of Cerebrospinal Fluid

artículo científico publicado en 2020

First-ever stroke and outcome in patients admitted to Perugia Stroke Unit: predictors for death, dependency, and recurrence of stroke within the first three months

artículo científico publicado en 2006

Free water elimination improves test-retest reproducibility of diffusion tensor imaging indices in the brain: A longitudinal multisite study of healthy elderly subjects.

artículo científico publicado en 2016

Genetics of ischemic stroke.

artículo científico publicado en 2002

Glucocerebrosidase in Parkinson's disease: Insights into pathogenesis and prospects for treatment

artículo científico publicado en 2016

Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease.

artículo científico publicado en 2003

Has the time arrived for cerebrospinal fluid biomarkers in psychiatric disorders?

scientific article published on 22 January 2019

Headache associated with acute ischemic stroke

artículo científico publicado en 2001

Heart-brain relationship: atrial fibrillation and stroke

artículo científico publicado en 2002

Hippocampal epileptogenesis in autoimmune encephalitis

artículo científico publicado en 2019

Hot water epilepsy and Mccune-Albright syndrome: a case report.

artículo científico publicado en 2008

Hyperhomocyst(e)inemia: a risk factor for cerebrovascular disease.

artículo científico publicado en 2002

IX Congresso Sindem: Italian Association for the study of Dementia linked to the Italian Neurological Society (SIN)

article

Immunological profile of silent brain infarction and lacunar stroke

artículo científico publicado en 2013

Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes

artículo científico publicado en 2017

Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson's Disease: Pulsatile versus Continuous Dopaminergic Stimulation

scientific article published on 08 April 2020

Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer's disease

artículo científico publicado en 2017

Influence of Dementia on Antithrombotic Therapy Prescribed before Stroke in Patients with Atrial Fibrillation

artículo científico publicado en 2006

Is ultrasound examination sufficient in the evaluation of patients with internal carotid artery severe stenosis or occlusion?

artículo científico publicado en 2003

Late-Onset Epilepsy With Unknown Etiology: A Pilot Study on Neuropsychological Profile, Cerebrospinal Fluid Biomarkers, and Quantitative EEG Characteristics

artículo científico publicado en 2020

Levetiracetam in newly diagnosed late-onset post-stroke seizures: a prospective observational study

artículo científico publicado en 2008

Levodopa may affect cortical excitability in Parkinson's disease patients with cognitive deficits as revealed by reduced activity of cortical sources of resting state electroencephalographic rhythms

scholarly article by Claudio Babiloni et al published January 2019 in Neurobiology of Aging

Levodopa treatment in Parkinson's disease: earlier or later?

artículo científico publicado en 2019

Long-Term Risk of Stroke After Transient Global Amnesia in Two Prospective Cohorts

artículo científico publicado en 2019

Longitudinal Study on Low-Dose Aspirin versus Placebo Administration in Silent Brain Infarcts: The Silence Study

artículo científico publicado en 2018

Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study

scientific article published on 06 April 2019

Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression.

artículo científico publicado en 2016

Longitudinal reproducibility of automatically segmented hippocampal subfields: A multisite European 3T study on healthy elderly

artículo científico publicado en 2015

Longitudinal reproducibility of default-mode network connectivity in healthy elderly participants: A multicentric resting-state fMRI study

artículo científico publicado en 2015

Lysosomal Ceramide Metabolism Disorders: Implications in Parkinson's Disease

artículo científico publicado en 2020

Lysosomal Dysfunction and α-Synuclein Aggregation in Parkinson's Disease: Diagnostic Links.

artículo científico publicado en 2016

Lysosomal enzyme activities as possible CSF biomarkers of synucleinopathies

artículo científico publicado en 2019

Lysosomal enzymes in PD: further evidence is needed

artículo científico publicado en 2014

Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease

artículo científico publicado en 2007

Magnetization transfer MRI in dementia disorders, Huntington's disease and parkinsonism

artículo científico publicado en 2015

Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: do fresh vs frozen samples differ?

artículo científico publicado en 2020

Molecular profiling in Parkinsonian syndromes: CSF biomarkers

artículo científico publicado en 2020

Multimodal use of computed tomography in early acute stroke, part 1.

artículo científico publicado en 2006

Neurofilament light chain as a biomarker in neurological disorders

artículo científico publicado en 2019

Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease

artículo científico publicado en 2005

New CSF biomarkers on the block

artículo científico publicado en 2016

No diurnal variation of classical and candidate biomarkers of Alzheimer's disease in CSF.

artículo científico publicado en 2016

Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization

artículo científico publicado en 2016

Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer's disease.

artículo científico publicado en 2018

Origin of α-mannosidase activity in CSF.

artículo científico publicado en 2017

PT593. CSF Beta-Amyloid and APOE E4 Related Decline in Episodic Memory over 12 months measured using the CANTAB in individuals with amnestic MCI: Results from the European-ADNI study.

artículo científico publicado en 2016

Parkinson's and Lewy body dementia CSF biomarkers

artículo científico publicado en 2019

Parkinsonism and cognitive impairment following chronic exposure to potassium cyanide.

artículo científico publicado en 2008

Pathways of neurodegeneration and experimental models of basal ganglia disorders: downstream effects of mitochondrial inhibition

artículo científico publicado en 2006

Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine

artículo científico publicado en 2016

Performance of aβ1-40, aβ1-42, total tau, and phosphorylated tau as predictors of dementia in a cohort of patients with mild cognitive impairment.

artículo científico publicado en 2012

Phospholipid autoantibodies: time for a new immuno-assay?

artículo científico publicado en 2002

Plasma Aβ42 as a Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study

scientific article published on 01 January 2019

Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [F]-Flutemetamol PET Scan Result

scientific article published on 11 December 2018

Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer's disease

scientific article published on 21 March 2019

Position paper of the Italian Society for the study of Dementias (SINDEM) on the proposal of a new lexicon on Alzheimer disease

artículo científico publicado en 2011

Preanalytical Confounding Factors in the Analysis of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: The Issue of Diurnal Variation

artículo científico publicado en 2015

Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer’s Disease: Structural Brain Biomarkers

artículo científico publicado en 2019

Prevalence and risk of progression of preclinical Alzheimer's disease stages: a systematic review and meta-analysis

artículo científico publicado en 2019

Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis

artículo científico publicado en 2015

Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies

artículo científico publicado en 2014

Recanalization of cervical artery dissection: influencing factors and role in neurological outcome

artículo científico publicado en 2003

Reciprocal Incremental Value of 18F-FDG-PET and Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment Patients Suspected for Alzheimer's Disease and Inconclusive First Biomarker

scientific article published on 01 January 2019

Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update

artículo científico publicado en 2012

Relevance of Aging in Carotid Disease: Results of a Population Survey

Risk factors and stroke subtypes: results of five consecutive years of the Perugia Stroke Registry

artículo científico publicado en 2006

Risk factors of levodopa-induced dyskinesia in Parkinson's disease: results from the PPMI cohort

scientific article published on 16 November 2018

Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS.

artículo científico

Role of CSF biomarkers in the diagnosis of prodromal Alzheimer's disease

artículo científico publicado en 2011

Secondary prevention of stroke in patients with atrial fibrillation: factors influencing the prescription of oral anticoagulation at discharge

artículo científico publicado en 2006

Selection of thrombogenetic antiphospholipid antibodies in cerebrovascular disease patients

artículo científico publicado en 2003

Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies.

artículo científico publicado en 2015

Semi-quantitative analysis of perfusion of Brodmann areas in the differential diagnosis of cognitive impairment in Alzheimer's disease, fronto-temporal dementia and mild cognitive impairment

artículo científico publicado en 2009

Serum neurofilament light chain as a preclinical marker of neurodegeneration

artículo científico publicado en 2019

Short-term and long-term plasticity at corticostriatal synapses: implications for learning and memory.

artículo científico publicado en 2008

Should CSF Biomarkers Support a Routine Analysis for Early Diagnosis of Alzheimer's Disease?

artículo científico publicado en 2010

Special Issue CCA for the proceedings of the 2nd symposium of the Society of CSF analysis and Clinical Neurochemistry

scientific article published on 06 December 2019

Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative

artículo científico publicado en 2011

Stroke prevention and atrial fibrillation: reasons leading to an inappropriate management. Main results of the SAFE II study

artículo científico publicado en 2004

Stroke prevention and statin treatment

artículo científico publicado en 2006

T2*-weighted MRI values correlate with motor and cognitive dysfunction in Parkinson's disease

artículo científico publicado en 2019

Test-retest reliability of the default mode network in a multi-centric fMRI study of healthy elderly: Effects of data-driven physiological noise correction techniques

artículo científico publicado en 2016

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

artículo científico publicado en 2011

The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases

artículo científico publicado en 2015

The Challenge of Disease-Modifying Therapies in Parkinson's Disease: Role of CSF Biomarkers

artículo científico publicado en 2020

The Clinical Use of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease Diagnosis: The Italian Selfie.

artículo científico publicado en 2016

The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design.

artículo científico publicado en 2016

The Italian version of Cognitive Function Instrument (CFI) for tracking changes in healthy elderly: results at 1-year follow-up

scientific article published on 12 June 2019

The Italian version of cognitive function instrument (CFI): reliability and validity in a cohort of healthy elderly.

artículo científico publicado en 2017

The Perugia hospital-based Stroke Registry: report of the 2nd year.

artículo científico publicado en 2002

The added value of Aβ42/Aβ40 in the CSF signature for routine diagnostics of Alzheimer's disease

artículo científico publicado en 2019

The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?

artículo científico publicado en 2014

The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative

artículo científico publicado en 2014

The inflammatory response in cerebral ischemia: focus on cytokines in stroke patients

artículo científico publicado en 2002

The issue of waste disposal in Parkinson's disease pathogenesis

artículo científico publicado en 2019

The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson's disease patients

scientific article published on 20 June 2019

The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature

artículo científico

The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunction

scientific article published on 15 November 2019

Therapeutic potential of autophagy-enhancing agents in Parkinson's disease.

artículo científico publicado en 2017

Treatment of Alzheimer's disease: from pharmacology to a better understanding of disease pathophysiology

artículo científico publicado en 2005

Two-Year Longitudinal Monitoring of Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease Using Topographical Biomarkers Derived from Functional Magnetic Resonance Imaging and Electroencephalographic Activity

artículo científico publicado en 2019

Unraveling Pathophysiological Mechanisms of Parkinson's Disease: Contribution of CSF Biomarkers

artículo científico publicado en 2020

Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study

artículo científico publicado en 2015

Validation of microRNAs in Cerebrospinal Fluid as Biomarkers for Different Forms of Dementia in a Multicenter Study

artículo científico publicado en 2016

Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosis

artículo científico publicado en 2016

White Matter Hyperintensities are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers

artículo científico publicado en 2020

White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation.

artículo científico publicado en 2018

cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases

artículo científico publicado en 2010

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda